# Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification

Study · id `cardio:ct-nct05774782` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05774782](<https://clinicaltrials.gov/study/NCT05774782>), retrieved 18 November 2026. No person wrote or checked this page.

Also called: NCT05774782

Browse, organ or system: Blood vessels; Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 143 participants.

## Technical summary

Registry record NCT05774782. Allocation not applicable; no masking; primary purpose treatment. Start 2023-03-27 (actual); primary completion 2024-06-23 (actual). Results not posted.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 143 participants (enrolled count; ClinicalTrials.gov record NCT05774782, source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)
- Started: 2023-03-27 (actual) (ClinicalTrials.gov record NCT05774782, source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)
- Primary completion: 2024-06-23 (actual) (ClinicalTrials.gov record NCT05774782, source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)
- Completion: 2024-08-30 (actual) (ClinicalTrials.gov record NCT05774782, source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)
- Countries: China (ClinicalTrials.gov record NCT05774782, source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05774782-2026-07-13`, retrieved 2026-11-18)

## The registry's words

- Brief title: Parent Artery Reconstruction for Cerebral Aneurysms Using a Novel Flow Diverter With Surface Modification
- Condition: Cerebral Aneurysm
- Condition: Cerebral Aneurysm Unruptured
- Intervention (Device): Cerebral flow diverter
- Lead sponsor: Sinomed Neurovita Technology Inc.
- Lead sponsor class: INDUSTRY
- Collaborator: Xuanwu Hospital, Beijing
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Brain aneurysm (intracranial aneurysm) (`cardio:intracranial-aneurysm`)
- Registry lists this organization as the lead sponsor: Sinomed Neurovita Technology Inc. (`cardio:org-sinomed-neurovita-technology-inc`)
- Registry lists this organization as a collaborator: Xuanwu Hospital, Beijing (`cardio:org-xuanwu-hospital-beijing`)

## Provenance

Content hash: 92a0941a93b0b62523dadd5cdbb2f20be4f0ecf209814b4a70b0f165ad298ab3
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
